Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Four SPACs Tap Markets for $530 Million Total (Law360)

Related Content

FTC Sues Private Equity Firm Welsh Carson and U.S. Anesthesia Partners Over Alleged Anesthesiology “Roll-Up Scheme” in Texas

Government Continues to Explore Role of 340B Contract Pharmacies

Antitrust & Competition Healthcare Quarterly Update Q2 2023

HHS OCR Proposes Changes to HIPAA to Support Reproductive Health Care Privacy

A Look Ahead in Life Sciences: What We Are Tracking in Q3 2023 and Beyond

FTC and DOJ Propose Major Changes to HSR Form and Disclosure

Starting in April 2024, California Joins Growing Trend of Implementing Advance Review Processes for Healthcare Transactions

The Supreme Court Holds that the False Claims Act’s Scienter Element Turns on Defendant’s Subjective Beliefs, Rejecting Seventh Circuit’s Objective Standard

Goodwin Names 40 New Partners

Matt Wetzel Named the 2023 Patricia T. Meador Leadership Award Recipient by the American Health Law Association

Goodwin Expands Life Sciences Practice with Capital Markets Partner Adam Johnson in New York

FemHealth Ventures Closes $32 Million Fund for Women’s Health Investments (The Wall Street Journal)

Inbound Health Completes $30 Million Series B

Openly Completes $100 Million Series D

Andreessen Horowitz-Backed Startup Health IQ Files For Bankruptcy (Forbes)

Goodwin Expands Philadelphia Presence with New Office Space in Burgeoning Innovation District

Healthcare

Life Sciences

Private Equity

Technology

Special Purpose Acquisition Companies (SPACs)